HBO 101 Metroplex Adventist Hospital January 11, 2010
Hyperbaric Oxygen Therapy (HBOT) H. Sprague Taveau IV, DO, MBA, FACOFP Medical Director
Center for Wound Care and Hyperbaric Medicine
Faculty Disclosure H. Sprague Taveau IV, DO, MBA, FACOFP It is the policy of Diversified Clinical Services and Metroplex Adventist hospital to ensure balance, independence, objectivity, and scientific rigor in all of its individually sponsored or jointly sponsored educational programs. Dr. Taveau is the Medical Director for Metroplex Adventist Hospital’s Center for Wound Care and Hyperbaric Medicine in Killeen, TX, and is a Regional Medical Director for Diversified Clinical Services. He has no other affiliations nor does he own stock in any company that produces equipment or products discussed in this presentation.
REGRETABLY!!
Objectives Become familiar with the fundamental aspects of wound healing and its interrelationship with oxygen Become familiar with the process of evaluating patients for and instituting hyperbaric oxygen therapy Recognize the physiologic and pharmacologic benefits of hyperbaric oxygen therapy
The Nine Essentials of Wound Healing 1. 2. 3. 4. 5. 6. 7. 8. 9.
Adequate Perfusion Non-Viable Tissue Inflammation or Infection Edema Wound Microenvironment Tissue Growth Optimized Off-Loading Pain Control Host Factors
Essential step 1: Adequate perfusion?
If You Don’t Get Water to the Garden, the Garden Won’t Grow!!
The Nine Essentials of Wound Healing 1. 2. 3. 4. 5. 6. 7. 8. 9.
Adequate Perfusion Non-Viable Tissue Inflammation or Infection Edema Wound Microenvironment Tissue Growth Optimized Off-Loading Pain Control Host Factors
The Nine Essentials of Wound Healing
If you can’t get water to the garden……the garden won’t grow!!!!
Essential step 2: Non viable tissue?
Wounds Won’t Heal in a SEWER!!
The Nine Essentials of Wound Healing 1. 2. 3. 4. 5. 6. 7. 8. 9.
Adequate Perfusion Non-Viable Tissue Inflammation or Infection Edema Wound Microenvironment Tissue Growth Optimized Off-Loading Pain Control Host Factors
The Nine Essentials of Wound Healing
Wounds Won’t Heal in a SEWER!!
Essential step 3: Inflammation or infection?
Wounds With BUGS Don’t Heal!!
The Nine Essentials of Wound Healing 1. 2. 3. 4. 5. 6. 7. 8. 9.
Adequate Perfusion Non-Viable Tissue Inflammation or Infection Edema Wound Microenvironment Tissue Growth Optimized Off-Loading Pain Control Host Factors
The Nine Essentials of Wound Healing
Wounds With BUGS Don’t Heal!!
Essential step 4: Edema?
Wounds Don’t Heal in a Swamp!!
The Nine Essentials of Wound Healing 1. 2. 3. 4. 5. 6. 7. 8. 9.
Adequate Perfusion Non-Viable Tissue Inflammation or Infection Edema Wound Microenvironment Tissue Growth Optimized Off-Loading Pain Control Host Factors
The Nine Essentials of Wound Healing
Wounds Don’t Heal in a Swamp!!
Essential step 5: Wound microenvironment conducive to healing?
Wounds Don’t Heal Unless The Environment Supports Healing
The Nine Essentials of Wound Healing 1. 2. 3. 4. 5. 6. 7. 8. 9.
Adequate Perfusion Non-Viable Tissue Inflammation or Infection Edema Wound Microenvironment Tissue Growth Optimized Off-Loading Pain Control Host Factors
The Nine Essentials of Wound Healing
Wounds Don’t Heal Unless The Environment Supports Healing
Essential step 6: Tissue growth optimized?
Tissue Growth is YOUR Business
The Nine Essentials of Wound Healing 1. 2. 3. 4. 5. 6. 7. 8. 9.
Adequate Perfusion Non-Viable Tissue Inflammation or Infection Edema Wound Microenvironment Tissue Growth Optimized Off-Loading Pain Control Host Factors
The Nine Essentials of Wound Healing
Tissue Growth is OUR Business
Essential step 7: Offloading, pressure relief?
Wounds Don’t Heal Under Pressure!!
The Nine Essentials of Wound Healing 1. 2. 3. 4. 5. 6. 7. 8. 9.
Adequate Perfusion Non-Viable Tissue Inflammation or Infection Edema Wound Microenvironment Tissue Growth Optimized Off-Loading Pain Control Host Factors
The Nine Essentials of Wound Healing
Wounds Don’t Heal Under Pressure!!
Essential step 8: Pain controlled?
Controlled Pain = Better Compliance
The Nine Essentials of Wound Healing 1. 2. 3. 4. 5. 6. 7. 8. 9.
Adequate Perfusion Non-Viable Tissue Inflammation or Infection Edema Wound Microenvironment Tissue Growth Optimized Off-Loading Pain Control Host Factors
The Nine Essentials of Wound Healing
Controlled Pain = Better Compliance
Essential step 9: Host factors optimized?
Wounds Don’t Heal Without Building Blocks!!
The Nine Essentials of Wound Healing 1. 2. 3. 4. 5. 6. 7. 8. 9.
Adequate Perfusion Non-Viable Tissue Inflammation or Infection Edema Wound Microenvironment Tissue Growth Optimized Off-Loading Pain Control Host Factors
The Nine Essentials of Wound Healing
Wounds Don’t Heal Without Building Blocks!!
Selecting Patients for HBO By
ability to reverse specific pathophysiology …of wound healing failure
By
diagnosis
Benefits of Hyperbaric Oxygen Physiologic Effects: • Improved leukocyte function and bacterial killing • Antibiotic potentiation • Enhanced collagen synthesis and cross-linking
Pharmacological Effects: • Direct antimicrobial effects, toxin synthesis suppression • Blunting of systemic inflammatory responses • Prevention of leukocyte activation and adhesion • PDGF-BB receptor stimulation (multiple effects) • VEGF release and angiogenesis • Detoxification (CO, CN, H2S)
Selecting Patients for HBO By
ability to reverse specific pathophysiology …of wound healing failure
By
diagnosis
Emergency/Acute Indications
Cerebral Arterial Air or Gas Embolism Carbon Monoxide Poisoning Cyanide Poisoning Hydrogen Sulfide Poisoning Clostridial Myositis & Myonecrosis Acute Traumatic Ischemia
Crush Injury Compartment Syndrome Replantation Limb/Digits Etc.
Emergency/Acute Indications Decompression Sickness Exceptional Blood Loss (Anemia) Intracranial Abscess Necrotizing Soft Tissue Infections Thermal Burns (Not CMS Approved) Combined Synergistic Necrotizing STI Compromised Skin Grafts/Flaps
Acute Traumatic Ischemia
4 year old slipped and fell into a riding lawn mower, sustaining a mid-calf amputation of his leg. Leg was successfully replanted. Ischemic time: 10 hours Tx’d aggressively with HBO
Acute Traumatic Ischemia
Appearance of muscle three days after replantation shows 100% viability as HBO counteracted reperfusion injury.
Acute Traumatic Ischemia
Three Months after Injury HBO @ 2.4 ATA x 90 minutes q8h x 6 Then q12h x 4
Acute Traumatic Ischemia
The result was excellent function of the leg. The patient regenerated his nerves and ended up with a sensate foot. He was able to walk and run with the aid of a brace.
Crush Injury
Crush Injury with avulsion of palmar skin
Appearance at time of presentation 1 hour after injury
Crush Injury
Elevation of avulsed palmar skin of crushed right hand
Crush Injury
Immediate post-op view Note vertical blue line through midpalm
Area not expected to survive
Crush Injury
11 weeks post injury HBO @ 2 ATA x 90 minutes q8h x 3 then q24h x 17
Crush Injury
11 weeks post injury Full range of motion
Non-approved Emergent Indications Retinal Artery Insufficiency Actinomycosis
Chronic/Elective Indications
Problem Wounds
Chronic Refractory Osteomyelitis Delayed Radiation Injury
Diabetic Foot Ulcers (Chronic; Wagner III) Arteriolar Insufficiency Etc.
Soft Tissue Bony
Meleny Ulcer (Invasive Group A Strep)
Age associated differences in cellular Proliferation (in vitro)…
11000 10000
Number of Cells
9000 8000 7000
New born Young adult Old adult
6000
NB 5000
YA 4000
OA
3000 2000 1000 0
0
1
2
3
4
5
6
7
8
9
10
11
12
13
Day
(Buras and Buras, Harvard Medical School, MGH, Boston)
Decreased cellular proliferation with diabetes…
35
30
# Cells X 10 4
25
20
15
Diabetic
10
Non-Diabetic 5 1
2
3
4
5
6
7
8
9
Days
(Buras and Buras, Harvard Medical School, MGH, Boston)
HBO Dramatically Increases Old Adult Fibroblast Proliferation…
(Buras and Buras, Harvard Medical School, MGH, Boston)
HBO Dramatically Increases Diabetic Fibroblast Proliferation… 30
# Cells X 10
4
25 20 15 Diabetic
10
Diabetic + HBO
5 1
2
3
4
5
6
7
8
Days
(Buras and Buras, Harvard Medical School, MGH, Boston)
9
PtcO2 As A Predictor of Wound Healing in Diabetic Foot Wounds… = Initial healing success = Initial healing failure
PtcO2 < 30 mmHg indicated 39 fold increased risk of early healing failure. Pecoraro, et al. Diabetes 40:1305-1313, 1991
Wound Healing Impairment with Decreasing PtcO2 40 mmHg
0 mmHg
118.0
110.3
158.7
68.0
2 hours pre…………………………2 hours post
Pre Smoking Baseline
Post Smoking
Smoking Effects on Benefit from HBO H B O T re a tm e n ts fo r S m o k e rs 120 110
M in im u m P la n n e d
Number of HBO Treatments Projected
100
E xp e cte d N u m b e r
90 80 70 60 50 40 30 20 10 0 0
10
20
30
40
50
60
70
80
90
100
110
P a ck- Y e a r s o f S m o kin g
The avg pt with > 10 pk/yrs who benefitted from HBOT needed 8-14 more HBO treatments than a non smoker for the same outcome (Otto & Fife, UHM 2000;27(2):83-89.
Ulcers
Grade 0: Intact skin Grade I: Superficial without penetration deeper layers Grade II: Deeper reaching tendon, bone, or joint capsule Grade III: Deeper with abscess, osteomyelitis, or tendonitis extending to those structures Grade IV: Gangrene of some portion of the toe, toes, and/or forefoot Grade V: Gangrene involving the whole foot or enough of the foot that no local procedures are possible
Grade I or II w/Infection = Grade III Wagner FW. Foot & Ankle 1981, 64-122
DFU Treated with HBO
DFU Treated with HBO
DFU Treated with HBO
DFU Treated with HBO
DFU Treated with HBO
DFU Treated with HBO
DFU Treated with HBO
DFU Treated with HBO
DFU
10/16/09
DFU
11/20/09
DFU
12/30/09
Problem Wounds
Achilles tendon rupture repair
4 months post-op Suture line breakdown 2 weeks post-op Multiple failed attempts at secondary closure
Problem Wounds
TCOMs in the periwound area demonstrated soft tissue hypoxia immediately adjacent to wound edges
Problem Wounds
5 weeks post-HBO HBO @ 2 ATA x 90 minutes q24h x 20 Routine wound care Oral antibiotics
Problem Wounds
Posterior view Excellent range of motion Ambulating without difficulty
Problem Wounds
Non-healing transmetatarsal amputation
Suture line breakdown 3 mos s/p Fem/Tib bypass
Considering BKA
Problem Wounds
10 weeks post-HBO
Complete healing No surgical debridement No revision No BKA
HBO @ 2 ATA x 90 minutes q24h x 20
Soft Tissue Radionecrosis
Malignant FibroHistiocytoma
Wide excision Radiation therapy
2 months post-op
Dehiscence Radionecrosis Purulent drainage
Soft Tissue Radionecrosis
Close-up view
9 x 6.5 cm Stage III/IV Ulceration
Soft Tissue Radionecrosis
1 week post-HBO
2 ATA 90 minutes each Q24h 20 treatments 5 days/week
Routine wound care Oral antibiotics
Soft Tissue Radionecrosis
10 days post-STSG Ambulating without difficulty No further procedures required
Compromised Flap
ORIF open fracture right Tibia
Wound break down Exposed plate Flap rotated Skin graft to donor site
Distal ischemia Impending necrosis
Compromised Flap
Post-HBO x 10 Treatments
Compromised Flap
Complete Healing
HBO @ 2.4 ATA x 90 minutes q12h x 6 Then 2 ATA x 90 minutes q24h x 14
No further procedures necessary
Old Absolute Contraindications Known
Malignancies
Increased
Pregnancy
Vascularity
Retrolentil
Fibroplasisa Premature Closure of PDA
Implanted
Pacemakers
Manufacturing
Defects
Absolute Contraindications
Untreated Pneumothorax Pregnancy (Almost)
Barotrauma ALL Barotrauma is directly related to BOYLE’S LAW V 1 P 1 = V2 P 2 V1P1
“The volume of a gas varies inversely with the absolute pressure (at a constant temperature)”
V2P2
LOPI
LOPI
LOPI
P
LOPI
P
LOPI
P
LOPI
P
LOPI
P
Relative Contraindications Upper Respiratory Infections Chronic Sinusitis Emphysema w/CO2 Retention High Fevers History of Seizure Disorder Pregnancy
Oxygen Toxicity: Pulmonary & Cardiac Bleomycin *(Pulmonary) Anthracyclines** (Cardiac)
Doxorubicin Taxotere Daunorubicin Epirubicin Idarubicin Mixoxantrone
*UNQUALIFIED ABSOLUTE CONTRAINDICATION to simultaneous administration with HBO. OK >1 year since last dose. Monitor pulmonary status closely. **For the anthracyclines, a last dose interval >6 weeks appears to be sufficient to allow initiation of HBO.
Chemotherapy and HBO Risks
Oxygen Toxicity (Cardiac, Pulmonary and CNS)
Alkylating Agents
Plant Alakaloids Anthracyclines (Unqualified Absolute Contraindication)
Antineoplastic/Cytotoxic Agents Anti-tumor Antibiotics Cyto-skeletal disrupters (Taxanes) Epipodophyllotoxins Epothilones Peptide Antibiotics Platinum Based Agents Topoisomerase II Inhibitors
Chemotherapy and HBO Risks Since there are no case series nor RCTs and very few case reports regarding chemotherapeutic agents and HBO, we can only extrapolate from information in the literature as it pertains to mechanism of action. In OUR OPINION, patients undergoing chemotherapy with the aforementioned agents should not be treated with HBO for at least 6 weeks or 5 half lives (whichever is longer) after their last dose of that agent.
Chemotherapy and HBO Risks
Probably Safe Monoclonal antibodies Nucleotide analogs and precursor analogs Retinoids
Medication and HBO Risks Amiodarone 1. Amiodarone has been associated with cases of acute pulmonary fibrosis in association with exposure to increased FiO2. 2. All cases reported (about 7 in the literature) have occurred in critically ill patients receiving the drug by intravenous administration which appears to lead to an increase in pulmonary uptake. 3. Animal models have demonstrated a similar occurrence. 4. All human cases have received Amidarone dosages > 200mg/day.
Medication and HBO Risks Amiodarone Our pulmonologist colleagues, with extensive HBO experience and some experience in treating patients receiving oral Amiodarone believe that it is probably safe at doses of < 200mg/day (all cases of toxicity reported in the literature were in the dose range of ≥ 400mg/day).
Medication and HBO Risks Amiodarone In light of this new information we have altered our position to allow HBO in patients receiving oral Amiodarone at doses < 200mg/day with a normal preHBO PFT and CXR. PFT and CXR should be repeated as indicated by the onset of pulmonary symptoms.
Relative Contraindications (Continued)
History of Surgery for Otosclerosis
Viral Infections
Get worse
Congenital Spherocytosis
PE tubes
Hemolysis in presence of increased paO2
History of Optic Neuritis
May be associated with blindness
Complications & Side Effects
Barotrauma of the Ear
PE tubes
CNS Oxygen Toxicity Pulmonary Oxygen Toxicity Visual Refractive Changes
Complications & Side Effects (Continued) Numb Fingers Dental Problems
Occult abcess
Claustrophobia
What’s on the HBO Horizon? The Latest on Potential Indications
Source Material Abstracts From the 38th Annual Undersea and Hyperbaric Medical Society Scientific Meeting 16-18 June, 2005 Las Vegas, Nevada
Chronic Wounds
ALL Chronic Wounds
Not JUST Diabetic Wounds
Hawkins, G.; et al
Radiation Induced Anosmia Eight of Nine Patients Improved Larger Study of Greater Duration Required
Johnson, E.G.; et al
Acute Acoustic Trauma (AAT)
HBO is Most Effective When started within 48 hours of injury When continued for 10 treatments
Concomitant Steroids are Contraindicated
Kapetanakis, E.; et al
Sub-Acute Global Cerebral Ischemia
Post Cardio-Respiratory Arrest
Effective well beyond hyper-acute reperfusion period
Further Formal Study Required
Murphy-Lavoie, H.; et al
Acute Traumatic Brain Injury Significant Decrease in Mortality Improved Speech, Language & Cognitive Function Further Study Recommended
Bennett, M.H.; et al, Hoggard, M.L.; et al
Acute Coronary Syndrome
Initial Studies Optimistic Improved Quality of Life No Improvement in Prolongation of Life
Further Study Recommended
Bennett, M.H.; et al
Acute Myocardial Infarction
The Dark Ages (Early 60’s & 70’s)
Too little, too late
The Renaissance (Late 70’s & 80’s) Controlled studies Improvement with HBO and Vasodilators
The Age of Rationality (Early 90’s)
Immediate HBO & Thrombolysis
Reduced infarct size by 95%
Hart, G.B.; et al
Acute Myocardial Infarction The
Age of Reason (The Present)
2
Hour Treatments at 2 ATA Pre and Post HBO Improves Long Term Patency PTCA CABG Coronary
Artery Stents Hart, G.B.; et al
Acute Myocardial Infarction
The Future Improved Long Term Patency Yet to be established
HBOT’s role in: – – – –
Hart, G.B.; et al
Reperfusion Injury (Mechanism now elucidated-2007) Endothelial Inflammatory Reaction Lipid Metabolism Angiogenesis of Myocardial Vasculature
Sepsis 79% Mortality – Untreated 65% Mortality – Treated
90 minutes BID @ 2.5 ATA
Reduction in splenic bacterial CFUs
Buras, J.A.; et al
UT/Hermann Memorial Multiplace
Perry Sigma 40
Perry Sigma 34
Seachrist 3600E
Seachrist 3200
Brooks AFB Research Chamber
Dive Ship Deck HBO “Can”
Hyperbaric Oxygen Therapy
Thanks for your attention! Do you have any questions?
[email protected]